• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries

    Author

    • Dr. PB Banerjee, Dr. Kota Ramya
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Lower abdominal surgeries are usually performed under subarachnoid block, also called spinal anesthesia. The drug which is routinely used for spinal anesthesia is 0.5% hyperbaric Bupivacaine. Addition of adjuvants to the hyperbaric Bupivacaine helps in prolonging the duration of anesthesia and provides better and prolonged post-operative analgesia.
Materials and Methods: This study was done on 100 ASA 1 & 2 patients between 18 and 70 years who underwent various lower abdominal surgeries at our hospital. Patients were divided into two groups, Group I were given 0.5% hyperbaric Bupivacaine and Group II were given 0.5% hyperbaric Bupivacaine along with 60 mcg Buprenorphine in the intrathecal space.
Results: The onset of sensory blockade was significantly earlier in patients in group I, while the duration of analgesia was significantly longer in group II, 426 ± 41.17 minutes as compared to 203.49 ± 41.35 minutes in group I. More than 80% patients in group II had mild post-operative pain only after 8 hours, whereas patients in group I started having moderate to severe pain after 4 hours. About 15% patients in group II experienced nausea, vomiting and drowsiness.
Conclusion: Buprenorphine is an effective adjuvant to provide prolonged post-operative analgesia with minimal hemodynamic changes and minor side effects

Keywords

  • Buprenorphine
  • Bupivacaine
  • sensory blockade
  • abdominal surgeries
  • duration of analgesia
  • XML
  • PDF 251.9 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 7
    • PDF Download: 23
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 2
February 2022
Page 3036-3042
Files
  • XML
  • PDF 251.9 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 7
  • PDF Download: 23

APA

Dr. Kota Ramya, D. P. B. (2023). Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries. European Journal of Molecular & Clinical Medicine, 9(2), 3036-3042.

MLA

Dr. PB Banerjee, Dr. Kota Ramya. "Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries". European Journal of Molecular & Clinical Medicine, 9, 2, 2023, 3036-3042.

HARVARD

Dr. Kota Ramya, D. P. B. (2023). 'Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries', European Journal of Molecular & Clinical Medicine, 9(2), pp. 3036-3042.

VANCOUVER

Dr. Kota Ramya, D. P. B. Comparison of intrathecal hyperbaric bupivacaine 0.5% with intrathecal hyperbaric bupivacaine 0.5% with low dose buprenorphine for post-operative analgesia in lower abdominal surgeries. European Journal of Molecular & Clinical Medicine, 2023; 9(2): 3036-3042.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus